Eighth Annual International Business Awards Announces 2011 Call for Entries
The Stevie® Awards today issued the call for entries for the Eighth Annual International Business Awards, the world's premier business awards competition which last year attracted nominations from more than 40 nations.
All individuals and organizations worldwide -- public and private, for-profit and non-profit, large and small -- may submit nominations to the IBAs. The early-bird entry deadline, offering discounted entry fees, is 12 April. The final entry deadline is 11 May. Late entries will be accepted through 8 June, and results will be announced in early July. Entry details are available at www.stevieawards.com/iba.
The Stevie Award trophy, made by the company that makes the Oscar and other major international awards, is one of the world's most coveted prizes. Stevies are conferred upon top-scoring nominations in each category, as chosen by an international judging panel of more than 150 business leaders.
The International Business Awards recognize achievement in every facet of the workplace. Categories include
For a full list of categories visit: http://www.stevieawards.com/pubs/iba/awards/171_695_3021.cfm.
"The International Business Awards are the preeminent indicator of achievement in the global business community," said Michael Gallagher, president of The Stevie Awards. "Each year we celebrate the achievements of individuals and organizations who are making a positive difference for their customers, their shareholders, their employees, and their communities."
2011 honorees will be celebrated at the 8th annual awards banquet on Tuesday, 11 October at the Emirates Palace Hotel in Abu Dhabi, hosted under the patronage of H.E. Sheikha Lubna Al Qassimi, Minister for Foreign Trade, United Arab Emirates.
The 7th Annual International Business Awards were presented in September 2010 in Istanbul, Turkey. Honorees included Accenture, Bank of Montreal, Cisco, Coca-Cola Icecek, Edelman in Indonesia, Nokia Corp., Samsung Electronics, and Thomson Reuters, among others. 2010 results are summarized at http://www.stevieawards.com/pubs/iba/awards/408_2633_20484.cfm.
To request an entry kit for The 2011 International Business Awards, visit www.stevieawards.com/iba.
About The Stevie Awards
Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about The Stevie Awards at http://www.stevieawards.com/, and follow the Stevie Awards on Twitter @TheStevieAwards.
Sponsors of The 2011 International Business Awards include IIR Exhibitions, the Korea Business Communications Association, Netezza Corporation, and Smart Reader Worldwide.
We've pleased to introduce the new mobile homepage for the Stevie Awards, the world's premier business awards. Please try it now – go to www.stevieawards.com on your smartphone.
From now on, most everyone around the world who visits a web page on the stevieawards.com domain on their smartphone will be greeted in their native language with a general introduction to the Stevie Awards that offers the opportunity to receive more information by email about one of our four awards programs, including
The American Business Awards
The International Business Awards
The Stevie Awards for Women in Business
The Stevie Awards for Sales & Customer Service
The languages included in the first edition of our new mobile homepage include Arabic, Chinese, French, German, Italian, Japanese, Korean, Portuguese, Russian, and Spanish. We’ll be adding other languages in time.
What do you think of our new mobile homepage?
March 31 is the final entry deadline for The 2011 (9th annual) American Business Awards, the premier business awards competition in the U.S.A. Late entries will be accepted through April 27 with payment of a late fee.
If you haven't yet reviewed the 2011 entry kit, you'll find it online here. We also recommend that you watch the video How to Enter The 2011 American Business Awards.
The ABAs have categories to recognize achievement in all facets of the American workplace, from the executive suite to the shop floor. Types of categories include:
2011 Finalists will be announced in mid-May, and this year's Stevie® Award winners will be announced at the 9th annual awards banquet at the Marriott Marquis Hotel in New York City on Monday, June 20. Finalists are not required to attend to win.
The ABAs are one of four Stevie Awards competitions. While the ABAs are open to all organizations operating in the U.S.A., the other three programs are open to entries from all organizations worldwide. The other competitions are The International Business Awards, the Stevie Awards for Sales & Customer Service, and the Stevie Awards for Women in Business.
If you have questions about The American Business Awards or any of the other Stevie Awards competitions, please contact us:
The Stevie Awards
Josef von Rickenbach, Chairman & CEO of PAREXEL International Corporation, with global headquarters located in Waltham, Massachusetts U.S.A., was named Executive of the Year in North America in the management awards categories of The 2010 International Business Awards. Here we profile his company and what it has achieved in nearly three decades.
Founded in 1982 by Joseph von Rickenbach, PAREXEL supports pharmaceutical, biotech, and medical-device companies throughout the world in the successful development and launch of products. Over the past 29 years the company has helped bring some of the most important treatments of our time to the patients who need them. PAREXEL has supported nearly all of the 50 top-selling drugs on the market, and has marked several firsts throughout its history, including helping to achieve one of the fastest drug-development times to date for an HIV/protease inhibitor.
Recently, PAREXEL has achieved marketing approval for among the first biosimilar drugs worldwide, helping to advance new versions of innovator biopharmaceutical products following patent expiry.
On a Mission
Under Mr. von Rickenbach’s leadership, PAREXEL’s mission has been clear: to prevent and cure disease. “We have maintained a clear focus on combining the strength of our expertise, experience, and innovation to advance the success of the biopharmaceutical industry in achieving this,” he said.
A proof point of this mission is PAREXEL’s work with biopharmaceutical companies to improve development success rates for oncology drugs. In 2009 the company announced it had reached a milestone in managing oncology-based clinical trials over the last five years. The trials involved over 175,000 patients in hundreds of programs across 80 countries—a critical achievement given that approximately 10 million people are diagnosed with cancer each year worldwide.
A Vision for Global Drug Development
Mr. von Rickenbach foresaw that pharmaceutical companies with separate national operations needed service providers that combined an international presence with the technology capabilities that would help develop and commercialize drugs for burgeoning international markets. By investing in this vision, PAREXEL has acted as an effective catalyst in this trend.
Today, PAREXEL has helped biopharmaceutical companies transcend national boundaries by providing access to a wide array of geographies for clinical development programs, and offering technologies that facilitate global trials and reduce associated time and cost.
A New Level of Strategic Partnership
Working with PAREXEL's management team, Mr. von Rickenbach has transformed the business in recent years to deliver a new level of strategic partnership.
In 2009 PAREXEL established The Expert Office™, signaling a new level of strategic partnering that provides a single point of contact for clients to more quickly access PAREXEL’s worldwide expertise. This service aligns the company’s leading medical, therapeutic-area, regulatory, and clinical operations experts with their counterparts at biopharmaceutical companies. This consolidation of knowledge helps biopharmaceutical companies make faster, better-informed development and commercialization decisions and accelerate clinical research.
After receiving the Stevie Award, Mr. von Rickenbach said: “I am honored to be recognized by the judges of The International Business Awards. I am proud of PAREXEL’s achievements, including the continued commitment of our employees worldwide to deliver on our goal to be a premier partner to the biopharmaceutical industry."
In addition to the recognition of Mr. von Rickenbach, the eClinical Suite from Perceptive Informatics, a subsidiary of PAREXEL, was named in The International Business Awards as Distinguished Honoree in the category of Best New Product or Service of the Year: Computer Software—New Version. This honor recognized PAREXEL’s focus on innovation and continuous investment in the next generation of technologies to accelerate clinical development.
About Josef von Rickenbach
Josef von Rickenbach has taken PAREXEL from pioneering beginnings as one of the first clinical research organizations in the early 1980s to its place today as one of the top three public biopharmaceutical services providers. As Chairman and CEO of PAREXEL, Mr. von Rickenbach was one of the first to define the clinical research service sector. To make clinical development more effective for clients, he conceived a multidisciplinary and systems-oriented approach to outsourced clinical development, bringing efficiencies, scalability, and standardization to the process.
Mr. von Rickenbach has led PAREXEL through its IPO, multiple public offerings, and over 30 acquisitions to expand its portfolio in order to meet changing client needs and market demand. Under his leadership, PAREXEL has evolved to provide a broad range of services to the biopharmaceutical industry, including integrated clinical development, regulatory affairs consulting, commercialization services, and technologies that expedite time-to-market. Mr. von Rickenbach’s extensive experience in the biopharmaceutical services industries puts him at the forefront of drug development and management. He began his career with Schering-Plough and also held positions with ENSECO (formerly ERCO).
Mr. von Rickenbach has served as Chair of the Association of Clinical Research Organizations (ACRO), and is a longstanding member of the ACRO Board of Directors. He also serves on the Board of Directors of the New England Healthcare Institute. He holds a B.S. degree in Business Economics from the School of Business at the Lucerne University of Applied Sciences in Switzerland, and a Master of Business Administration degree from Harvard University.
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications, and consulting services to the worldwide pharmaceutical, biotechnology, and medical device industries. For more information about PAREXEL visit www.PAREXEL.com.
A Portion of Proceeds From All 2011 Business Award Programs to Benefit Fight Against Poverty and HIV/AIDS in Africa
The Stevie Awards, organizers of the world's premier business awards, today named Camfed, a non-profit organization that aims to fight poverty and HIV/AIDS in Africa, as the sole non-profit beneficiary of its programs this year.
As the beneficiary of the Stevie Awards, Camfed will receive a portion of every ticket sold for each of the four Stevie Awards shows in 2011 including The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service.
Camfed (http://www.camfed.org) is an organization dedicated to fighting poverty and HIV/AIDS in Africa by educating girls and empowering women to become leaders of change in their communities. With more than 90 percent of Camfed's operating budget going directly to programs in Africa, the organization benefits millions of girls in Africa. For example, they have improved the school environment for 1,065,710 children, provided scholarships for 42,184 girls to go to high school, trained 4,068 teacher mentors and helped 769 young women go to college.
"We are honored to have the support of a national organization like The Stevie Awards and the global business community," said Kristin Harrison, Camfed's Strategic Communications Manager. "With additional funding and increased awareness of Camfed, we will be able to put more children in Africa on the path to success and extend our fight against poverty and AIDS."
In addition to the monetary contribution, Camfed will receive $50,000 worth of advertising and editorial coverage on the Stevie Awards web sites and email newsletter. The Stevie Awards (www.stevieawards.com) recognize outstanding performance in the workplace worldwide, and communicate with hundreds of thousands of business professionals each year.
"For our beneficiary this year, we wanted to select an organization with a mission to provide brighter futures for tomorrow's generation of potential leaders," said Michael Gallagher, president of The Stevie Awards. "Camfed's mission to stop the spread of poverty and HIV/AIDS in Africa not only supports education and health, but also facilitates the start of small businesses on a continent that needs them vitally."
About The Stevie® Awards
Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.stevieawards.com.
Camfed fights poverty and HIV/AIDS in Africa by educating girls and empowering women to become leaders of change. Our goal: To improve the lives of two million children by 2013. For more information please visit: http://www.camfed.org.